Reversible opening of the blood-brain barrier by anti-bacterial antibodies

E. I. Tuomanen; S. M. Prasad; J. S. George; A. I.M. Hoepelman; P. Ibsen; I. Heron; R. M. Starzyk

doi:10.1073/pnas.90.16.7824

Reversible opening of the blood-brain barrier by anti-bacterial antibodies

E. I. Tuomanen^*, S. M. Prasad, J. S. George, A. I.M. Hoepelman, P. Ibsen, I. Heron, R. M. Starzyk

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Abstract

The leukocyte adhesion molecule CR3 (CD11b/CD18, Mac-1) promotes leukocyte transmigration into tissues by engaging an unknown cognate ligand on the surface of vascular endothelial cells. Filamentous hemagglutinin (FHA), an adhesin of the bacterium Bordetella pertussis, binds to CR3. We hypothesized that FHA mimics the native ligand for the CR3 integrin on endothelial cells and predicted that anti-FHA antibodies should bind to endothelial cells, interfere with leukocyte recruitment, and induce endothelial permeability. Anti-FHA monoclonal antibodies bound to cerebral microvessels in sections from human brain and upon intravenous injection into rabbits. Antibody binding correlated with the ability to recognize two polypeptides in extracts of human cerebral vessels that were also bound by CD18. In vivo, antibody binding not only interfered with transmigration of leukocytes into cerebrospinal fluid but also induced a dose-dependent reversible increase in blood-brain barrier permeability sufficient to improve delivery of intravenously administered therapeutic agents to brain parenchyma.

Original language	English
Pages (from-to)	7824-7828
Number of pages	5
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	90
Issue number	16
DOIs	https://doi.org/10.1073/pnas.90.16.7824
Publication status	Published - 1 Jan 1993

Access to Document

10.1073/pnas.90.16.7824

Cite this

@article{1998a2a85f08423ba7b07fab3f41bed3,

title = "Reversible opening of the blood-brain barrier by anti-bacterial antibodies",

abstract = "The leukocyte adhesion molecule CR3 (CD11b/CD18, Mac-1) promotes leukocyte transmigration into tissues by engaging an unknown cognate ligand on the surface of vascular endothelial cells. Filamentous hemagglutinin (FHA), an adhesin of the bacterium Bordetella pertussis, binds to CR3. We hypothesized that FHA mimics the native ligand for the CR3 integrin on endothelial cells and predicted that anti-FHA antibodies should bind to endothelial cells, interfere with leukocyte recruitment, and induce endothelial permeability. Anti-FHA monoclonal antibodies bound to cerebral microvessels in sections from human brain and upon intravenous injection into rabbits. Antibody binding correlated with the ability to recognize two polypeptides in extracts of human cerebral vessels that were also bound by CD18. In vivo, antibody binding not only interfered with transmigration of leukocytes into cerebrospinal fluid but also induced a dose-dependent reversible increase in blood-brain barrier permeability sufficient to improve delivery of intravenously administered therapeutic agents to brain parenchyma.",

author = "Tuomanen, {E. I.} and Prasad, {S. M.} and George, {J. S.} and Hoepelman, {A. I.M.} and P. Ibsen and I. Heron and Starzyk, {R. M.}",

year = "1993",

month = jan,

day = "1",

doi = "10.1073/pnas.90.16.7824",

language = "English",

volume = "90",

pages = "7824--7828",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "16",

}

TY - JOUR

T1 - Reversible opening of the blood-brain barrier by anti-bacterial antibodies

AU - Tuomanen, E. I.

AU - Prasad, S. M.

AU - George, J. S.

AU - Hoepelman, A. I.M.

AU - Ibsen, P.

AU - Heron, I.

AU - Starzyk, R. M.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The leukocyte adhesion molecule CR3 (CD11b/CD18, Mac-1) promotes leukocyte transmigration into tissues by engaging an unknown cognate ligand on the surface of vascular endothelial cells. Filamentous hemagglutinin (FHA), an adhesin of the bacterium Bordetella pertussis, binds to CR3. We hypothesized that FHA mimics the native ligand for the CR3 integrin on endothelial cells and predicted that anti-FHA antibodies should bind to endothelial cells, interfere with leukocyte recruitment, and induce endothelial permeability. Anti-FHA monoclonal antibodies bound to cerebral microvessels in sections from human brain and upon intravenous injection into rabbits. Antibody binding correlated with the ability to recognize two polypeptides in extracts of human cerebral vessels that were also bound by CD18. In vivo, antibody binding not only interfered with transmigration of leukocytes into cerebrospinal fluid but also induced a dose-dependent reversible increase in blood-brain barrier permeability sufficient to improve delivery of intravenously administered therapeutic agents to brain parenchyma.

AB - The leukocyte adhesion molecule CR3 (CD11b/CD18, Mac-1) promotes leukocyte transmigration into tissues by engaging an unknown cognate ligand on the surface of vascular endothelial cells. Filamentous hemagglutinin (FHA), an adhesin of the bacterium Bordetella pertussis, binds to CR3. We hypothesized that FHA mimics the native ligand for the CR3 integrin on endothelial cells and predicted that anti-FHA antibodies should bind to endothelial cells, interfere with leukocyte recruitment, and induce endothelial permeability. Anti-FHA monoclonal antibodies bound to cerebral microvessels in sections from human brain and upon intravenous injection into rabbits. Antibody binding correlated with the ability to recognize two polypeptides in extracts of human cerebral vessels that were also bound by CD18. In vivo, antibody binding not only interfered with transmigration of leukocytes into cerebrospinal fluid but also induced a dose-dependent reversible increase in blood-brain barrier permeability sufficient to improve delivery of intravenously administered therapeutic agents to brain parenchyma.

UR - http://www.scopus.com/inward/record.url?scp=0027169649&partnerID=8YFLogxK

U2 - 10.1073/pnas.90.16.7824

DO - 10.1073/pnas.90.16.7824

M3 - Article

C2 - 8102802

AN - SCOPUS:0027169649

SN - 0027-8424

VL - 90

SP - 7824

EP - 7828

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 16

ER -

Reversible opening of the blood-brain barrier by anti-bacterial antibodies

Abstract

Access to Document

Other files and links

Fingerprint

Cite this